B.C. doctor finds cure to his burnout via primary-care researchDr. Scott Garrison returned to UBC for a PhD and answers to questions that arise in his practice Chemo tops radiation for Hodgkin lymphoma survival‘I think we will see that more doctors will move toward chemotherapy alone for these patients,’ researcher says Common drugs linked to nocturnal leg cramps In those older than 50, cramps can be a serious problem for one in 50 patients Oral anticoagulant options expand Prescription opioid monitoring database fails to curb illicit use Maine sees big increases in prescriptions despite program Triple therapy for multiple myeloma disappoints in experienced patients Heavily treated patients had much lower response rate than that seen in other studies Vorinostat offers small boost in progression-free survival for multiple myeloma Drug approved for T-cell lymphoma is often prescribed off-label for other hematological disorders All together now Chronic pain clinic in Alberta shows how collaborative care makes all the difference Case Study: Chronic Pain A closer look at collaborative care in action Eliquis: third new oral anticoagulant in Canada It is the third new oral anticoagulant to reach the Canadian market, joining rivaroxaban and dabigatran etexilate. OxyNEO soon to replace OxyContin Purdue Pharma will be discontinuing OxyContin at the end of this month. Putting care on the same page Medication reconciliation a priority for these community and hospital practitioners in Nova Scotia First Previous 838 839 840 841 842 Next Last
